LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

Black garlic, a fermented form of regular garlic, offers enhanced antioxidant and anti-inflammatory benefits due to its ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly.

These ten large-cap stocks were top performers last week. Are they a part of your portfolio? AST SpaceMobile, Inc.

An AST SpaceMobile launch last year. Shares of the space-based cellular network provider rose on Wednesday. (Cristobal Herrera-Ulashkevich/EPA/Shutterstock) ↘️ ...

Vertex Pharmaceuticals Incorporated today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company's most recently ...

Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue ...

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...